PMC:7306567 / 2576-2674
Annnotations
LitCovid-PMC-OGER-BB
{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T33","span":{"begin":17,"end":34},"obj":"CHEBI:35705;CHEBI:35705"},{"id":"T96288","span":{"begin":17,"end":34},"obj":"CHEBI:35705;CHEBI:35705"}],"text":" and duration of immunosuppressive therapy [1]. Patients at the highest risk of invasive aspergill"}
2_test
{"project":"2_test","denotations":[{"id":"32572532-25354514-47963394","span":{"begin":44,"end":45},"obj":"25354514"},{"id":"T48775","span":{"begin":44,"end":45},"obj":"25354514"}],"text":" and duration of immunosuppressive therapy [1]. Patients at the highest risk of invasive aspergill"}